A Phase II Placebo-Controlled Trial of Modafinil to Improve Neurocognitive Deficits in Children Treated for a Primary Brain Tumor
The purpose of this trial is to study how well modafinil works in treating children with memory and attention problems caused by cancer treatment for a brain tumor. Modafinil may help improve memory, attention, and fatigue caused by cancer treatment.
Stanford is not currently accepting new patients for this trial. You may want to check clinicaltrials.gov to see if other locations are recruiting.
- drug : modafinil
- other : placebo
Phase: Phase 2
Ages Eligible For Study: